Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Wound Repair Regen ; 32(3): 279-291, 2024.
Article in English | MEDLINE | ID: mdl-38353052

ABSTRACT

Pressure ulcer (PU) is a worldwide problem that is difficult to address because of the related inflammatory response, local hypoxia, and repeated ischaemia/reperfusion, causing great suffering and financial burden to patients. Traditional Chinese medicine turtle plate powder can treat skin trauma, but its composition is complex and inconvenient to use. Here, we combined cholesterol myristate (S8) with berberine (BBR), with anti-inflammatory and antibacterial effects, as a drug and used hydroxypropyl methylcellulose and polyvinylpyrrolidone K30 as carriers to construct a novel film-forming polymeric solution (S8 + BBR FFPS), comprehensively study its reparative effect on PU and explore the potential mechanism in rat PU models. The results showed that S8 + BBR FFPS inhibits excessive inflammatory response, promotes re-epithelialization, and promotes hair follicle growth during the healing process of PU, which may be related to the activation of the Wnt/ß-catenin signalling pathway by S8 + BBR FFPS to mediate hair follicle stem cell proliferation and maintain skin homeostasis. Therefore, S8 + BBR FFPS may be a potential candidate for the treatment of chronic skin injury, and its association with the Wnt/ß-catenin signalling pathway may provide new ideas to guide the design of biomaterial-based wound dressings for chronic wound repair.


Subject(s)
Berberine , Disease Models, Animal , Pressure Ulcer , Rats, Sprague-Dawley , Wnt Signaling Pathway , Wound Healing , Animals , Pressure Ulcer/drug therapy , Berberine/pharmacology , Berberine/therapeutic use , Rats , Wound Healing/drug effects , Wnt Signaling Pathway/drug effects , Male , Polymers/pharmacology , Cell Proliferation/drug effects
2.
J Cell Mol Med ; 25(6): 2885-2899, 2021 03.
Article in English | MEDLINE | ID: mdl-33534963

ABSTRACT

Inflammation is a biological process that exists in a large number of diseases. If the magnitude or duration of inflammation becomes uncontrolled, inflammation may cause pathological damage to the host. HMGB1 and NF-κB have been shown to play pivotal roles in inflammation-related diseases. New drugs aimed at inhibiting HMGB1 expression have become a key research focus. In the present study, we showed that paeonol (Pae), the main active component of Paeonia suffruticosa, decreases the expression of inflammatory cytokines and inhibits the translocation of HMGB1 induced by lipopolysaccharide (LPS). By constructing HMGB1-overexpressing (HMGB1+ ) and HMGB1-mutant (HMGB1m ) RAW264.7 cells, we found that the nuclear HMGB1 could induce an LPS-tolerant state in RAW264.7 cells and that paeonol had no influence on the expression of inflammatory cytokines in HMGB1m RAW264.7 cells. In addition, the anti-inflammatory property of paeonol was lost in HMGB1 conditional knockout mice, indicating that HMGB1 is a target of paeonol and a mediator through which paeonol exerts its anti-inflammatory function. Additionally, we also found that HMGB1 and P50 competitively bound with P65, thus inactivating the NF-κB pathway. Our research confirmed the anti-inflammation property of paeonol and suggests that inhibiting the translocation of HMGB1 could be a new strategy for treating inflammation.


Subject(s)
Acetophenones/pharmacology , Active Transport, Cell Nucleus/drug effects , Anti-Inflammatory Agents/pharmacology , HMGB1 Protein/metabolism , Acetophenones/chemistry , Animals , Anti-Inflammatory Agents/chemistry , Cell Nucleus/metabolism , Disease Models, Animal , Gene Expression Profiling , HMGB1 Protein/chemistry , HMGB1 Protein/genetics , Inflammation/drug therapy , Inflammation/etiology , Inflammation/metabolism , Inflammation/pathology , Male , Mice , Mice, Knockout , Models, Molecular , NF-kappa B/metabolism , Protein Transport , RAW 264.7 Cells , Signal Transduction/drug effects , Structure-Activity Relationship
3.
Int Immunopharmacol ; 89(Pt B): 107068, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33091813

ABSTRACT

Phagocytosis is a basic immune response to the pathogens invading. Immunosuppression may occur in diseases like sepsis and cancer, and cause a low phagocytic ability of phagocytes. High mobility group protein B1 (HMGB1) is a DNA chaperone which is closely related to the phagocytosis. Nonetheless, its influence on phagocytosis is still controversial. We found that paeonol could inhibit the translocation of HMGB1 from the nucleus to the cytoplasm, it may have an impact on phagocytosis. In the present study, we performed in vivo and in vitro experiments to investigate the influence of paeonol on phagocytosis. Zymosan was used to test the phagocytic function of macrophages. Our results showed that paeonol promotes the phagocytosis of macrophages through confining HMGB1 to the nucleus. Through interacting with P53, the nuclear HMGB1 keep it in the nucleus and decrease the negative influence of P53 on the phosphorylation of Focal Adhesion Kinase (FAK). The increasing of phosphorylated FAK promotes the formation of pseudopod and enhances the phagocytic ability of macrophages.


Subject(s)
Acetophenones/pharmacology , Cell Nucleus/drug effects , HMGB1 Protein/metabolism , Macrophages/drug effects , Phagocytosis/drug effects , Active Transport, Cell Nucleus , Animals , Cell Nucleus/metabolism , Focal Adhesion Kinase 1/metabolism , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Phosphorylation , Pseudopodia/drug effects , Pseudopodia/metabolism , RAW 264.7 Cells , Signal Transduction , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...